• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[立场文件:奥地利视角下开源技术在糖尿病患者治疗中的应用:奥地利糖尿病协会技术委员会]

[Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association].

作者信息

Kietaibl Antonia-Therese, Schütz-Fuhrmann Ingrid, Bozkurt Latife, Frühwald Lisa, Rami-Merhar Birgit, Fröhlich-Reiterer Elke, Hofer Sabine E, Tauschmann Martin, Resl Michael, Hörtenhuber Thomas, Stechemesser Lars, Winhofer Yvonne, Riedl Michaela, Zlamal-Fortunat Sandra, Eichner Marlies, Stingl Harald, Schelkshorn Christian, Weitgasser Raimund, Rega-Kaun Gersina, Köhler Gerd, Mader Julia K

机构信息

5. Medizinische Abteilung für Endokrinologie, Rheumatologie und Akutgeriatrie, Klinik Ottakring, Wien, Österreich.

Verein zur Förderung der wissenschaftlichen Forschung am Wilhelminenspital, Wien, Österreich.

出版信息

Wien Klin Wochenschr. 2024 Jul;136(Suppl 9):467-477. doi: 10.1007/s00508-024-02400-x. Epub 2024 Aug 28.

DOI:10.1007/s00508-024-02400-x
PMID:39196351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11358222/
Abstract

People living with diabetes mellitus can be supported in the daily management by diabetes technology with automated insulin delivery (AID) systems to reduce the risk of hypoglycemia and improve glycemic control as well as the quality of life. Due to barriers in the availability of AID-systems, the use and development of open-source AID-systems have internationally increased. This technology provides a necessary alternative to commercially available products, especially when approved systems are inaccessible or insufficiently adapted to the specific needs of the users. Open-source technology is characterized by worldwide free availability of codes on the internet, is not officially approved and therefore the use is on the individual's own responsibility. In the clinical practice a lack of expertise with open-source AID technology and concerns about legal consequences, lead to conflict situations for health-care professionals (HCP), sometimes resulting in the refusal of care of people living with diabetes mellitus. This position paper provides an overview of the available evidence and practical guidance for HCP to minimize uncertainties and barriers. People living with diabetes mellitus must continue to be supported in education and diabetes management, independent of the chosen diabetes technology including open-source technology. Check-ups of the metabolic control, acute and chronic complications and screening for diabetes-related diseases are necessary and should be regularly carried out, regardless of the chosen AID-system and by a multidisciplinary team with appropriate expertise.

摘要

糖尿病患者在日常管理中可借助糖尿病技术及自动胰岛素输注(AID)系统获得支持,以降低低血糖风险,改善血糖控制及生活质量。由于AID系统的可及性存在障碍,开源AID系统在国际上的使用和开发有所增加。这项技术为市售产品提供了必要的替代方案,特别是在无法获得获批系统或现有系统无法充分满足用户特定需求的情况下。开源技术的特点是代码在互联网上全球免费可用,未经官方批准,因此使用由个人自行负责。在临床实践中,缺乏开源AID技术专业知识以及对法律后果的担忧,给医护人员(HCP)带来了冲突情况,有时导致拒绝为糖尿病患者提供护理。本立场文件概述了现有证据,并为医护人员提供了实用指南,以尽量减少不确定性和障碍。糖尿病患者必须在教育和糖尿病管理方面持续获得支持,无论选择何种糖尿病技术,包括开源技术。无论选择何种AID系统,都应由具备适当专业知识的多学科团队定期进行代谢控制、急慢性并发症检查以及糖尿病相关疾病筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b5/11358222/f966efaee967/508_2024_2400_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b5/11358222/e25cb47b6ab5/508_2024_2400_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b5/11358222/f966efaee967/508_2024_2400_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b5/11358222/e25cb47b6ab5/508_2024_2400_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1b5/11358222/f966efaee967/508_2024_2400_Fig2_HTML.jpg

相似文献

1
[Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association].[立场文件:奥地利视角下开源技术在糖尿病患者治疗中的应用:奥地利糖尿病协会技术委员会]
Wien Klin Wochenschr. 2024 Jul;136(Suppl 9):467-477. doi: 10.1007/s00508-024-02400-x. Epub 2024 Aug 28.
2
Do-it-yourself closed-loop systems for people living with type 1 diabetes.1 型糖尿病患者的 DIY 闭环系统。
Diabet Med. 2020 Dec;37(12):1977-1980. doi: 10.1111/dme.14321. Epub 2020 Jun 24.
3
Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.为什么#我们不等待-开源自动化胰岛素输送系统使用者的动机和自我报告结果:多国调查。
J Med Internet Res. 2021 Jun 7;23(6):e25409. doi: 10.2196/25409.
4
Practical Guidance on Open Source and Commercial Automated Insulin Delivery Systems: A Guide for Healthcare Professionals Supporting People with Insulin-Requiring Diabetes.开源和商业自动胰岛素输送系统实用指南:面向支持胰岛素依赖型糖尿病患者的医疗保健专业人员的指南。
Diabetes Ther. 2022 Sep;13(9):1683-1699. doi: 10.1007/s13300-022-01299-9. Epub 2022 Aug 1.
5
Association of British Clinical Diabetologists, Diabetes Technology Network UK and Association of Children's Diabetes Clinicians Survey of UK Healthcare Professional Attitudes Towards Open-Source Automated Insulin Delivery Systems.英国临床糖尿病学家协会、英国糖尿病技术网络以及儿童糖尿病临床医生协会关于英国医疗保健专业人员对开源自动胰岛素输送系统态度的调查。
Diabetes Ther. 2022 Feb;13(2):341-353. doi: 10.1007/s13300-022-01203-5. Epub 2022 Jan 31.
6
Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management.观点对撞:1 型糖尿病管理中 DIY 开源 (OS) AID 系统的必要性。
Diabetes Technol Ther. 2024 Oct;26(10):689-699. doi: 10.1089/dia.2024.0073. Epub 2024 May 13.
7
Health Care Provider Knowledge and Perceptions of FDA-Approved and Do-It-Yourself Automated Insulin Delivery.医疗保健提供者对 FDA 批准和 DIY 自动化胰岛素输送的知识和看法。
J Diabetes Sci Technol. 2020 Nov;14(6):1017-1021. doi: 10.1177/1932296819895567. Epub 2019 Dec 26.
8
Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers.1 型糖尿病的 DIY 和商业化自动胰岛素输送系统:加拿大医疗保健提供者面临的不确定领域。
Can J Diabetes. 2022 Dec;46(8):863-870. doi: 10.1016/j.jcjd.2022.06.003. Epub 2022 Jun 22.
9
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.美国临床内分泌医师协会临床实践指南:先进技术在糖尿病患者管理中的应用
Endocr Pract. 2021 Jun;27(6):505-537. doi: 10.1016/j.eprac.2021.04.008.
10
Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review.基于开源和商业自动化胰岛素输注系统的 1 型糖尿病患者临床结局的真实世界证据:一项系统评价。
Diabet Med. 2022 May;39(5):e14741. doi: 10.1111/dme.14741. Epub 2021 Nov 24.

本文引用的文献

1
Retrospective Comparison of Commercially Available Automated Insulin Delivery With Open-Source Automated Insulin Delivery Systems in Type 1 Diabetes.1型糖尿病中商用自动胰岛素输注与开源自动胰岛素输注系统的回顾性比较
J Diabetes Sci Technol. 2024 Feb 16:19322968241230106. doi: 10.1177/19322968241230106.
2
A comparison of the usage of an open-source automated insulin delivery system and the MiniMed™ 780 G system in children and adolescents with type 1 diabetes in real-world settings: the AWeSoMe study group.在真实环境中比较开源自动化胰岛素输送系统和 MiniMed™ 780G 系统在儿童和青少年 1 型糖尿病患者中的使用:AWeSoMe 研究组。
Endocrine. 2024 Jun;84(3):943-950. doi: 10.1007/s12020-024-03683-w. Epub 2024 Jan 16.
3
Introduction and Methodology: Standards of Care in Diabetes-2024.
引言与方法:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Supplement_1):S1-S4. doi: 10.2337/dc24-SINT.
4
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024.6. 血糖目标与低血糖:2024年糖尿病诊疗标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S111-S125. doi: 10.2337/dc24-S006.
5
7. Diabetes Technology: Standards of Care in Diabetes-2024.7. 糖尿病技术:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S126-S144. doi: 10.2337/dc24-S007.
6
A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective.从学术的欧盟/英国/美国角度来看医疗器械和糖尿病治疗中使用的数据的互操作性的叙述性评论。
Diabetologia. 2024 Feb;67(2):236-245. doi: 10.1007/s00125-023-06049-5. Epub 2023 Dec 2.
7
Area deprivation and demographic factors associated with diabetes technology use in adults with type 1 diabetes in Germany.德国 1 型糖尿病患者中,与糖尿病技术使用相关的地区贫困和人口统计学因素。
Front Endocrinol (Lausanne). 2023 Aug 1;14:1191138. doi: 10.3389/fendo.2023.1191138. eCollection 2023.
8
Do-It-Yourself Automated Insulin Delivery: A Health-care Practitioner User's Guide.自助式自动胰岛素输注:医护人员用户指南。
Can J Diabetes. 2023 Jul;47(5):389-397.e8. doi: 10.1016/j.jcjd.2023.06.001.
9
Do-It-Yourself Automated Insulin Delivery: A Position Statement.自助式自动胰岛素给药:一份立场声明。
Can J Diabetes. 2023 Jul;47(5):381-388. doi: 10.1016/j.jcjd.2023.05.006.
10
Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade.糖尿病技术的使用与十年来成年 1 型糖尿病患者血糖控制结果的关系。
Diabetes Care. 2023 Sep 1;46(9):1646-1651. doi: 10.2337/dc23-0495.